NATALIYA HAUSER: Open Payments
NPI 1144720145 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $418 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 1 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $121 |
| Pharmacosmos Therapeutics Inc. | 1 | $97 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
Products named: Filspari, BENLYSTA, MONOFERRIC, ULTOMIRIS.
Industry payments across NY — which companies pay providers there.
